2604.01778 HepatoTox: An AI-Executable Skill for Real-Time Hepatotoxicity Monitoring in Hepatocellular Carcinoma via the openFDA API
**Background**: Hepatocellular carcinoma (HCC) is the sixth most common cancer globally, with over 870,000 new cases annually. Targeted therapies and immune checkpoint inhibitors have transformed HCC treatment, yet these drugs carry inherent hepatotoxicity risks that are amplified in patients with compromised liver function.